Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Simultaneous multianalyte immunoassay measurement of five serum tumor markers in the detection of colorectal cancer.

Lumachi F, Marino F, Orlando R, Chiara GB, Basso SM.

Anticancer Res. 2012 Mar;32(3):985-8.

PMID:
22399621
2.
3.

Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.

Guadagni F, Kantor J, Aloe S, Carone MD, Spila A, D'Alessandro R, Abbolito MR, Cosimelli M, Graziano F, Carboni F, Carlini S, Perri P, Sciarretta F, Greiner JW, Kashmiri SV, Steinberg SM, Roselli M, Schlom J.

Cancer Res. 2001 Mar 15;61(6):2523-32.

4.
5.

Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.

Reiter W, Stieber P, Reuter C, Nagel D, Lau-Werner U, Lamerz R.

Anticancer Res. 2000 Nov-Dec;20(6D):5195-8.

PMID:
11326694
6.

Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: a receiver operating characteristic curve analysis.

Körner H, Söreide K, Stokkeland PJ, Söreide JA.

Ann Surg Oncol. 2007 Feb;14(2):417-23.

PMID:
17103264
7.

[Detection and clinical study of serum tumor markers in patients with colorectal cancer].

Zhao XW, Jiang B, Han CZ, Jing JX.

Zhonghua Zhong Liu Za Zhi. 2005 May;27(5):286-8. Chinese.

PMID:
15996321
8.

NuMA: evaluation of a new biomarker for the detection of low stage colorectal cancer.

Briggman J, Genduso R, Camara C, Healy B, Shapiro K, Roos R, Merrifield S, Lifter J, Wu YJ, Elder E, Talamonti M.

Anticancer Res. 1999 Jul-Aug;19(4A):2411-4.

PMID:
10470167
9.

Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring.

Feng B, Zheng MH, Zheng YF, Lu AG, Li JW, Wang ML, Ma JJ, Xu GW, Liu BY, Zhu ZG.

J Gastroenterol Hepatol. 2005 Dec;20(12):1913-9.

PMID:
16336453
10.
11.

Utility of serum cytokeratin 19 fragment (CYFRA 21-1) and carcinoembryonic antigen (CEA) as tumour markers for non-small cell lung cancer.

Chantapet P, Riantawan P, Lebnak P, Getngern P.

J Med Assoc Thai. 2000 Apr;83(4):383-91.

PMID:
10808698
12.

Assessment of serum CYFRA 21-1 in lung cancer.

Muraki M, Tohda Y, Iwanaga T, Uejima H, Nagasaka Y, Nakajima S.

Cancer. 1996 Apr 1;77(7):1274-7.

PMID:
8608502
13.

Utility of serum preoperative carcinoemberyonic antigen in colorectal cancer patients.

El-Awady S, Lithy R, Morshed M, Khafagy W, Abd Monem H, Waleed O, Badr S, Fekry A, El Nakeeb A, Ghazy H, El Yamany M, Metwally T, El-Arman M, Farid M.

Hepatogastroenterology. 2009 Mar-Apr;56(90):361-6.

PMID:
19579599
14.

TAG-72 (CA 72-4 assay) as a complementary serum tumor antigen to carcinoembryonic antigen in monitoring patients with colorectal cancer.

Guadagni F, Roselli M, Cosimelli M, Mannella E, Tedesco M, Cavaliere F, Grassi A, Abbolito MR, Greiner JW, Schlom J.

Cancer. 1993 Oct 1;72(7):2098-106.

PMID:
8374868
16.

Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.

Wu X, Lu XH, Xu T, Qian JM, Zhao P, Guo XZ, Yang XO, Jiang WJ.

Chin J Dig Dis. 2006;7(3):170-4.

PMID:
16808798
17.

Prediagnostic levels of carcinoembryonic antigen and CA 242 in colorectal cancer: a matched case-control study.

Palmqvist R, Engarås B, Lindmark G, Hallmans G, Tavelin B, Nilsson O, Hammarström S, Hafström L.

Dis Colon Rectum. 2003 Nov;46(11):1538-44.

PMID:
14605576
18.

Clinical evaluation of serum tumour markers CEA, CA 50 and CA 242 in colorectal cancer.

Eskelinen M, Pasanen P, Kulju A, Janatuinen E, Miettinen P, Poikolainen E, Tarvainen R, Nuutinen P, Pääkkönen M, Alhava E.

Anticancer Res. 1994 May-Jun;14(3B):1427-32.

PMID:
8067718
20.

Supplemental Content

Support Center